ANI Pharmaceuticals ANIP
$ 53.14
-2.06%
Quarterly report 2024-Q3
added 11-08-2024
ANI Pharmaceuticals Cash and Cash Equivalents 2011-2024 | ANIP
Annual Cash and Cash Equivalents ANI Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
221 M | 48.2 M | 100 M | 7.86 M | 62.3 M | 43 M | 31.1 M | 27.4 M | 155 M | 169 M | 11.1 M | 11 K | 57.2 M |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
221 M | 11 K | 71.8 M |
Quarterly Cash and Cash Equivalents ANI Pharmaceuticals
2024-Q3 | 2024-Q2 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
145 M | 240 M | 193 M | 162 M | 67.8 M | 48.2 M | 56.3 M | 63.4 M | 76.9 M | 100 M | 15.3 M | 24.3 M | 25.1 M | 7.86 M | 7.86 M | 7.86 M | 7.86 M | 62.3 M | 62.3 M | 62.3 M | 62.3 M | 43 M | 43 M | 43 M | 43 M | 31.1 M | 31.1 M | 31.1 M | 31.1 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 155 M | 155 M | 155 M | 155 M | 169 M | 169 M | 169 M | 169 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 11 K | 11 K | 11 K | 34.8 M | - | 57.2 M | 57.2 M | 57.2 M |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
240 M | 11 K | 66.3 M |